CERo Therapeutics announces 1-for-20 reverse stock split effective June 13

• CERo Therapeutics (NASDAQ:CERO) will implement a 1-for-20 reverse stock split on June 13, 2025.
• The split reduces outstanding common shares from ~10.32M to ~516,092.
• The stock will begin trading on a split-adjusted basis on Nasdaq at market open on June 13.
• Source: Press release

More on CERo Therapeutics Holdings, Inc.

• CERo Therapeutics announces up to $8M Series D financing; shares up
• Seeking Alpha’s Quant Rating on CERo Therapeutics Holdings, Inc.
• Historical earnings data for CERo Therapeutics Holdings, Inc.
• Financial information for CERo Therapeutics Holdings, Inc.